This is a preview of subscription content, log in via an institution to check access.
Notes
2019 US dollars
Reference
Blommestein HM, et al. Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma. JAMA Network Open : 29 Mar 2021. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2021.3497
Rights and permissions
About this article
Cite this article
Novel therapies not cost effective for MM in the Netherlands. PharmacoEcon Outcomes News 875, 21 (2021). https://doi.org/10.1007/s40274-021-7600-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7600-8